{"id":"W2998080630","doi":"10.1136/ijgc-2019-esgo.9","title":"Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Internal medicine; Oncology; Neutropenia; Population; Clinical endpoint; Chemotherapy; Progression-free survival; Gastroenterology; Randomized controlled trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00100689,0.0007176573,0.001588059,0.000290552,0.000281543,0.0008268846,0.0004137073,0.0007309407,0.002022566],"category_scores_gemma":[0.0008310149,0.0004709954,0.001957259,0.0005192276,0.0004245044,0.0006179918,0.0004214242,0.001520244,0.0004818024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004811096,"about_ca_system_score_gemma":0.0006770451,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007611832,"about_ca_topic_score_gemma":0.00260945,"domain_scores_codex":[0.9996246,0.0001518368,0.00002656462,0.00009159485,0.00004221042,0.00006320512],"domain_scores_gemma":[0.9994955,0.00009687293,0.0001366019,0.00006836361,0.0000285465,0.0001741413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5703137,0.01177394,0.267064,0.002741749,0.01162805,0.001268423,0.0002810439,0.00147797,0.01637804,0.000605786,0.00630649,0.1101607],"study_design_scores_gemma":[0.2935072,0.1377903,0.5169675,0.0004851393,0.0177597,0.002621546,0.0003738395,0.001961275,0.002875153,0.001022437,0.02448242,0.0001535863],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866092,0.008663372,0.0002615444,0.0003413793,0.0001284216,0.0004325001,0.001541549,0.00001967564,0.002002384],"genre_scores_gemma":[0.9873334,0.005186198,0.0005460432,0.0008385075,0.0002414142,0.000383559,0.003411199,0.00002013118,0.002039449],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002022566,"threshold_uncertainty_score":0.00676614,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01315348476993589,"score_gpt":0.3148937811599277,"score_spread":0.3017402963899918,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}